Matches in SemOpenAlex for { <https://semopenalex.org/work/W2212102491> ?p ?o ?g. }
- W2212102491 endingPage "9561" @default.
- W2212102491 startingPage "9546" @default.
- W2212102491 abstract "Hepatitis C virus (HCV) is a major cause of end-stage liver disease. Direct-acting antivirals (DAAs), including inhibitors of nonstructural proteins (NS3/4A protease, NS5A, and NS5B polymerase), represent key components of anti-HCV treatment, but these are associated with increased drug resistance and toxicity. Thus, the development of host-targeted antiviral agents, such as cyclophilin A inhibitors, is an alternative approach for more effective, selective, and safer treatment. Starting with the discovery of a bis-amide derivative 5 through virtual screening, the lead compound 25 was developed using molecular modeling-based design and systematic exploration of the structure-activity relationship. The lead 25 lacked cytotoxicity, had potent anti-HCV activity, and showed selective and high binding affinity for CypA. Unlike cyclosporin A, 25 lacked immunosuppressive effects, successfully inhibited the HCV replication, restored host immune responses without acute toxicity in vitro and in vivo, and exhibited a high synergistic effect in combination with other drugs. These findings suggest that the bis-amides have significant potential to extend the arsenal of HCV therapeutics." @default.
- W2212102491 created "2016-06-24" @default.
- W2212102491 creator A5000433225 @default.
- W2212102491 creator A5006822398 @default.
- W2212102491 creator A5008393937 @default.
- W2212102491 creator A5009590263 @default.
- W2212102491 creator A5012945820 @default.
- W2212102491 creator A5019128485 @default.
- W2212102491 creator A5022042072 @default.
- W2212102491 creator A5027007415 @default.
- W2212102491 creator A5027155826 @default.
- W2212102491 creator A5027299280 @default.
- W2212102491 creator A5031502955 @default.
- W2212102491 creator A5045542242 @default.
- W2212102491 creator A5058868448 @default.
- W2212102491 creator A5069098946 @default.
- W2212102491 creator A5073499303 @default.
- W2212102491 creator A5074647962 @default.
- W2212102491 creator A5074972294 @default.
- W2212102491 creator A5076382281 @default.
- W2212102491 creator A5078116082 @default.
- W2212102491 date "2015-12-08" @default.
- W2212102491 modified "2023-09-25" @default.
- W2212102491 title "Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections" @default.
- W2212102491 cites W1482367278 @default.
- W2212102491 cites W1534651025 @default.
- W2212102491 cites W1539277792 @default.
- W2212102491 cites W1808615540 @default.
- W2212102491 cites W1972510693 @default.
- W2212102491 cites W1980609312 @default.
- W2212102491 cites W1986115000 @default.
- W2212102491 cites W1987495635 @default.
- W2212102491 cites W1993496957 @default.
- W2212102491 cites W1995483624 @default.
- W2212102491 cites W1997514631 @default.
- W2212102491 cites W1997671040 @default.
- W2212102491 cites W2000676831 @default.
- W2212102491 cites W2001458978 @default.
- W2212102491 cites W2002980277 @default.
- W2212102491 cites W2005895808 @default.
- W2212102491 cites W2019689527 @default.
- W2212102491 cites W2022103755 @default.
- W2212102491 cites W2029994291 @default.
- W2212102491 cites W2035804055 @default.
- W2212102491 cites W2037648619 @default.
- W2212102491 cites W2039803856 @default.
- W2212102491 cites W2046658390 @default.
- W2212102491 cites W2062153657 @default.
- W2212102491 cites W2066725789 @default.
- W2212102491 cites W2067741095 @default.
- W2212102491 cites W2078887917 @default.
- W2212102491 cites W2080999910 @default.
- W2212102491 cites W2081814597 @default.
- W2212102491 cites W2083811181 @default.
- W2212102491 cites W2089924322 @default.
- W2212102491 cites W2097420398 @default.
- W2212102491 cites W2106478851 @default.
- W2212102491 cites W2107391918 @default.
- W2212102491 cites W2107512529 @default.
- W2212102491 cites W2120733999 @default.
- W2212102491 cites W2127378043 @default.
- W2212102491 cites W2134867985 @default.
- W2212102491 cites W2136197001 @default.
- W2212102491 cites W2143522905 @default.
- W2212102491 cites W2147526777 @default.
- W2212102491 cites W2148165153 @default.
- W2212102491 cites W2151690631 @default.
- W2212102491 cites W2152561379 @default.
- W2212102491 cites W2160783401 @default.
- W2212102491 cites W2168008491 @default.
- W2212102491 cites W2170609967 @default.
- W2212102491 cites W4211051574 @default.
- W2212102491 doi "https://doi.org/10.1021/acs.jmedchem.5b01064" @default.
- W2212102491 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26613291" @default.
- W2212102491 hasPublicationYear "2015" @default.
- W2212102491 type Work @default.
- W2212102491 sameAs 2212102491 @default.
- W2212102491 citedByCount "14" @default.
- W2212102491 countsByYear W22121024912016 @default.
- W2212102491 countsByYear W22121024912017 @default.
- W2212102491 countsByYear W22121024912019 @default.
- W2212102491 countsByYear W22121024912020 @default.
- W2212102491 countsByYear W22121024912021 @default.
- W2212102491 countsByYear W22121024912022 @default.
- W2212102491 countsByYear W22121024912023 @default.
- W2212102491 crossrefType "journal-article" @default.
- W2212102491 hasAuthorship W2212102491A5000433225 @default.
- W2212102491 hasAuthorship W2212102491A5006822398 @default.
- W2212102491 hasAuthorship W2212102491A5008393937 @default.
- W2212102491 hasAuthorship W2212102491A5009590263 @default.
- W2212102491 hasAuthorship W2212102491A5012945820 @default.
- W2212102491 hasAuthorship W2212102491A5019128485 @default.
- W2212102491 hasAuthorship W2212102491A5022042072 @default.
- W2212102491 hasAuthorship W2212102491A5027007415 @default.
- W2212102491 hasAuthorship W2212102491A5027155826 @default.
- W2212102491 hasAuthorship W2212102491A5027299280 @default.
- W2212102491 hasAuthorship W2212102491A5031502955 @default.
- W2212102491 hasAuthorship W2212102491A5045542242 @default.